Leducq Foundation
A GREAT WINE,
A GREAT CAUSE.... 
Ehlers Estate is held in trust by the non-profit Leducq Foundation. 100% of our proceeds fund research for cardiovascular diseases.
The Leducq Foundation (Fondation Leducq)
History: As a passionate philanthropist and a longtime sufferer from heart disease, Jean Leducq, and his wife Sylviane, established the Leducq Foundation to help fund cardiovascular research in 1996. The foundation was created with the idea that the fight against cardiovascular disease is international in scope. By forging and funding scientific alliances that transcend national borders, it efficiently uses its resources to support innovative cardiovascular research, while promoting international cooperation. No other foundation focuses in this area, and very few make international collaboration a cornerstone of the granting process.
Jean Leducq
Early on, the foundation was able to benefit from the help of eminent leaders in cardiology and cardiovascular surgery, who, in an inaugural meeting held in Paris in 1999, helped to define the mission, objectives and guidelines of the foundation. The Leducq Foundation awarded its first research grants in both Europe and the United States later that same year.
As part of its endowment, the Leducq Foundation holds Ehlers Estate in trust, with all proceeds from the sale of Ehlers Estate wines supporting the foundation’s philanthropic mission.
Mission: The mission of the Leducq Foundation is to improve human health through international efforts to combat cardiovascular disease.
The 20th century bore witness to great strides in the understanding, diagnosis and treatment of cardiovascular disease. Impressive developments in therapeutics, from technological and surgical interventions to innovative pharmaceuticals, have prevented the deaths and eased the suffering of many. Yet there is still much to be done.
Cardiovascular disease is a leading cause of death and disability worldwide. It is now recognized that cardiovascular disease, including hypertension, is a significant health problem in the developing world. Worldwide, the burden of this disease affects well over one billion people, and is increasing.
The Leducq Foundation is dedicated to funding cutting-edge, international cardiovascular research in the ongoing fight against this disease.
